Dicaffeoylquinic acid

二咖啡酰奎尼酸

Report date: 2023/06/28 16:02:27
NME

Base Information

Drug NameDicaffeoylquinic acid
Drug Alias NameIBE-5
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV integrase inhibitors
TargetsHIV integrase
Therapy Area/IndicationsHepatitis BHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHepatitis BHIV Infections

Other Information

ATC CodeN/A
Related LinksWikipedia